GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the A/BRISBANE/10/2007 (H3N2) influenza virus hemagglutinin L194P mutant apo form

Analyse Crystal structure of the A/BRISBANE/10/2007 (H3N2) influenza virus… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6AOP
Type
protein
Length
490 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hemagglutinin HA1 chain; Hemagglutinin HA2 chain
UniProt
I6UCL3, A8W891
Ligands
NAG, BMA, MAN
Pockets
4 · best druggability 0.57

Structure

x-ray diffraction · 2 distinct chains · 24% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHemagglutinin HA1 chainprotein3179% helix, 41% strandI6UCL3
BHemagglutinin HA2 chainprotein17350% helix, 16% strandA8W891

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 10 copies · chains A, B
  • BMA · beta-D-mannopyranose · sugar · 2 copies
  • MAN · alpha-D-mannopyranose · sugar · 2 copies

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1520.570.9117empty
21030.390.7619empty
3750.330.7516empty
4570.280.7415empty

Interfaces

1 interface between chains.

  • A–B · 3077 Ų buried · 44 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 glycan, 6 disulfide (N-glycosylation, disulfide).

Compared structures

  • 6AOP · Crystal structure of the A/Brisbane/10/2007 (H3N2) influenza virus hemagglutinin L194P… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.